References
- Michell R H. Peptide regulatory factors. Post-receptor signalling pathways. Lancet 1989; 1: 765–768
- Öhman P, Aurell M, Asplund J, et al. A long-term follow-up of patients with essential hypertension treated with captopril. Acta Med Scand 1084; 216: 53–56
- Williams L L, Lopez L M, Thorman A D, et al. Comparative effects of enalapril, lisinopril and nitrendipine on plasma lipid concentrations in hypertensive subjects. Drug intelligence and Clinical Pharmacy 1987; 24A: 22
- Costa F V, Borghi C, Boschi S, Ambrosioni E. Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: Long-term effects on metabolic values and intracellular electrolytes. J Cardiovasc Pharmacol 1985; 7(suppl l)70–75
- Weinberger M H. Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 1983; 5(suppl. 3)132–138
- Sasaki J, Arakawa K. Effect of captopril on serum lipids, lipoproteins, and apolipoproteins in patients with mild essential hypertension. Curr Ther Res 1986; 40: 898–902
- Jain A, McMahon F G, Ryan J, et al. A Comparative study of the antihypertensive efficacy and tolerability of enalapril and propranolol and their effects on serum lipids. Curr Ther Res Clin Exp 1987; 42: 737–747
- Gomez H J, et al. Enalapril attenuates hydrochlorothiazide-induced hypokalemia, hyperglycemia, hyperuricemia and hypercholesterolemia. First International Conference on Diuretics, Miami, Florida, March, 1984
- Leren P, Foss P O, Nordvik B, Fossbakk B. A randomized multicenter hypertension study in general practice in Norway. Acta Med Scand 1988; 223: 321–326
- Saltvedt E, Andreassen P, Dahl K, et al. An improved serum lipid profile in hypertensives during captopril treatment. Postgraduate Med J 1986; 62(suppl 1)78
- Passa P, LeBlanc H, Marre M. Efects of enalapril in insulin-dependent diabetic subjects with mild to moderate uncomplicated hypertension. Diabetes Care 1987; 10: 200–204
- Kannel W B, Castelli W P, Gordon T, McNarmara P M. Serum cholesterol, lipoproteins and risk of coronary heart disease. The Framingham Study. Ann Int Med 1971; 74: 1–12
- Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation 1973; 48: 950–958
- Samuelsson O, Wilhelmsen L, Andersson O, et al. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the Primary Prevention Trial in Gothenburg, Sweden. JAMA 1987; 258: 1768–1776